- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Ulm, Universität Ulm, Dissertation, 2017
- Schlagwort
-
NADH
Alzheimerkrankheit
Mitochondrium
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2018
- Urheber
- DOI
-
10.18725/OPARU-5431
- URN
-
urn:nbn:de:bsz:289-oparu-5488-1
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schäfer, Patrick Michael
- Universität Ulm
Entstanden
- 2018
Ähnliche Objekte (12)
NADH fluorescence lifetime imaging microscopy reveals selective mitochondrial dysfunction in neurons overexpressing alzheimer’s disease–related proteins
Urinary metabolic phenotyping for Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Quantitative multimodal multiparametric imaging in Alzheimer’s disease
Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective
Imaging endpoints for clinical trials in Alzheimer’s disease
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Systemic and central nervous system metabolic alterations in Alzheimer’s disease
PET molecular imaging for pathophysiological visualization in Alzheimer’s disease
PET imaging of mGluR5 in Alzheimer’s disease
NADH fluorescence lifetime imaging microscopy reveals selective mitochondrial dysfunction in neurons overexpressing alzheimer’s disease–related proteins
Urinary metabolic phenotyping for Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Quantitative multimodal multiparametric imaging in Alzheimer’s disease
Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective
Imaging endpoints for clinical trials in Alzheimer’s disease
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Systemic and central nervous system metabolic alterations in Alzheimer’s disease
PET molecular imaging for pathophysiological visualization in Alzheimer’s disease
PET imaging of mGluR5 in Alzheimer’s disease
NADH fluorescence lifetime imaging microscopy reveals selective mitochondrial dysfunction in neurons overexpressing alzheimer’s disease–related proteins
Urinary metabolic phenotyping for Alzheimer’s disease
Amyloid PET imaging: applications beyond Alzheimer’s disease
Quantitative multimodal multiparametric imaging in Alzheimer’s disease
Decoding metabolic signatures in Alzheimer’s disease: a mitochondrial perspective
Imaging endpoints for clinical trials in Alzheimer’s disease
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Systemic and central nervous system metabolic alterations in Alzheimer’s disease
PET molecular imaging for pathophysiological visualization in Alzheimer’s disease